Indo US Bio-Tech

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: INE250Z01010
  • NSEID: INDOUS
  • BSEID: 541304
INR
102.35
-10.5 (-9.3%)
BSENSE

Mar 09

BSE+NSE Vol: 1.71 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Mar'23
Sep'22
Mar'22
Sep'21
Sep'19
Mar'19
Sep'18
Net Sales
33.61
28.13
24.55
25.51
18.02
17.34
18.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
33.61
28.13
24.55
25.51
18.02
17.34
18.00
Raw Material Cost
25.73
21.74
17.66
19.68
14.83
13.62
14.81
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.85
0.67
0.41
0.30
0.33
0.01
0.58
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.68
0.51
0.57
0.61
0.43
0.40
0.00
Selling and Distribution Expenses
3.23
2.49
3.76
2.66
1.27
1.86
1.88
Other Expenses
-1.53
-1.18
-0.98
-0.91
-0.76
-0.41
-0.58
Total Expenditure (Excl Depreciation)
28.96
24.23
21.42
22.34
16.10
15.48
16.69
Operating Profit (PBDIT) excl Other Income
4.65
3.90
3.13
3.17
1.92
1.87
1.31
Other Income
0.02
0.00
0.16
0.02
0.00
0.01
0.01
Operating Profit (PBDIT)
5.17
4.23
3.61
3.33
2.04
1.97
1.49
Interest
0.68
0.51
0.57
0.61
0.43
0.40
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
-0.00
0.00
Gross Profit (PBDT)
7.88
6.40
6.89
5.83
3.19
3.72
3.20
Depreciation
0.50
0.33
0.32
0.14
0.11
0.09
0.17
Profit Before Tax
3.99
3.40
2.72
2.59
1.50
1.49
1.33
Tax
-0.15
0.30
0.12
0.12
0.29
0.47
0.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
4.14
3.10
2.60
2.46
1.21
1.02
1.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
4.14
3.10
2.60
2.46
1.21
1.02
1.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
4.14
3.10
2.60
2.46
1.21
1.02
1.07
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
54.50
50.34
38.51
23.80
15.12
13.91
12.86
Earnings per share (EPS)
2.07
1.68
2.1
1.69
0.83
0.7
0.78
Diluted Earnings per share
2.07
1.68
2.1
1.69
0.83
0.7
0.78
Operating Profit Margin (Excl OI)
13.83%
13.87%
12.75%
12.44%
10.68%
10.76%
7.29%
Gross Profit Margin
13.35%
13.24%
12.41%
10.68%
8.94%
9.08%
8.28%
PAT Margin
12.33%
11.01%
10.59%
9.65%
6.72%
5.86%
5.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Mar 2023 is 19.48% vs 14.58% in Sep 2022

stock-summary

Consolidate Net Profit

Growth in half year ended Mar 2023 is 33.55% vs 19.23% in Sep 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Mar 2023 is 21.75% vs 22.61% in Sep 2022

stock-summary

Interest

Growth in half year ended Mar 2023 is 33.33% vs -10.53% in Sep 2022

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Mar 2023 has fallen from Sep 2022

Compare Half Yearly Results Of Indo US Bio-Tech With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
33.61
521.27
-487.66
-93.55%
Other Operating Income
0.00
0.00
0.00
Total Operating income
33.61
521.27
-487.66
-93.55%
Raw Material Cost
25.73
420.90
-395.17
-93.89%
Purchase of Finished goods
0
5.87
-5.87
-100.00%
(Increase) / Decrease In Stocks
0
-23.33
23.33
100.00%
Employee Cost
0.85
36.46
-35.61
-97.67%
Power Cost
0
0.00
0.00
Manufacturing Expenses
0.68
0.00
0.68
Selling and Distribution Expenses
3.23
0.00
3.23
Other Expenses
-1.53
80.05
-81.58
-101.91%
Total Expenditure (Excl Depreciation)
28.96
519.95
-490.99
-94.43%
Operating Profit (PBDIT) excl Other Income
4.65
1.32
3.33
252.27%
Other Income
0.02
1.04
-1.02
-98.08%
Operating Profit (PBDIT)
5.17
2.36
2.81
119.07%
Interest
0.68
12.08
-11.40
-94.37%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
7.88
-9.72
17.60
181.07%
Depreciation
0.50
10.02
-9.52
-95.01%
Profit Before Tax
3.99
-19.74
23.73
120.21%
Tax
-0.15
-4.81
4.66
96.88%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
4.14
-14.92
19.06
127.75%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0.00
0.00
Other Adjustments
0
0.00
0.00
Net Profit
4.14
-14.92
19.06
127.75%
Share in Profit of Associates
0.00
2.20
-2.20
-100.00%
Minority Interest
0.00
-0.32
0.32
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
4.14
-13.04
17.18
131.75%
Equity Capital
0
3.16
-3.16
-100.00%
Face Value
10.00
5.00
0.00
Reserves
54.50
0.00
54.50
Earnings per share (EPS)
2.07
-5.16
7.23
140.12%
Diluted Earnings per share
2.07
-5.16
7.23
140.12%
Operating Profit Margin (Excl OI)
13.83%
0.25%
0.00
13.58%
Gross Profit Margin
13.35%
-1.86%
0.00
15.21%
PAT Margin
12.33%
-2.44%
0.00
14.77%
Public Share Holdings (%)
0%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 33.61 Cr
in Mar 2023

Figures in Cr
stock-summary

Growth in half year ended Mar 2023 is 19.48% vs 14.58% in Sep 2022

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 4.14 Cr
in Mar 2023

Figures in Cr
stock-summary

Growth in half year ended Mar 2023 is 33.55% vs 19.23% in Sep 2022

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.15 Cr
in Mar 2023

Figures in Cr
stock-summary

Growth in half year ended Mar 2023 is 21.75% vs 22.61% in Sep 2022

Half Yearly - Interest
Interest 0.68 Cr
in Mar 2023

Figures in Cr
stock-summary

Growth in half year ended Mar 2023 is 33.33% vs -10.53% in Sep 2022

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.83%
in Mar 2023

Figures in %
stock-summary

Growth in half year ended Mar 2023 has fallen from Sep 2022